These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13815860)

  • 1. [Anabolic and metabolic effects during nor-androstenolone phenylpropionate (NAPP) therapy].
    DEMOLE R; THIERY M; FRANCOIS-TERMONT E; BEKAERT J; PEETERS H; VUYLSTEKE P
    Praxis; 1960 May; 49():477-86. PubMed ID: 13815860
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic study of a new anabolic drug: nor-androstenolone phenylpropionate].
    ZARA M; LUMBROSO A
    Sem Hop Ther Paris; 1960 May; 36():454-7. PubMed ID: 13847031
    [No Abstract]   [Full Text] [Related]  

  • 3. [PREVENTIVE ACTION OF NOR-ANDROSTENOLONE PHENYLPROPIONATE (N.A.P.P.) IN EXPERIMENTAL TUMORIZATION. (NEW SERIES)].
    VERNE J; ROTH PC
    Bull Assoc Fr Etud Cancer; 1964; 51():287-90. PubMed ID: 14219567
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
    BEKENY G; KRAFT F; LANG S
    Orv Hetil; 1960 Feb; 101():229-34. PubMed ID: 13798373
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
    BEKENY G; KRAFT F; LANG S
    Nervenarzt; 1960 Mar; 31():118-23. PubMed ID: 13798372
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nor-androstenolone phenylpropionate (N.A.P.P) as an adjuvant in the treatment of marasmus].
    CORTES MARTINEZ A
    Arch Col Med El Salv; 1961 Sep; 14():131-44. PubMed ID: 13881499
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on anabolic agents. I. Comparative study of the anabolic action of methandrostenolone (MA) and of 19-nortestosterone phenylpropionate (NTP) in the same individuals. II. Anabolic action of a depot form of methandrostenolone].
    de SALCEDO ; SOUSA CG
    J Med (Oporto); 1962 Apr; 47():979-82. PubMed ID: 14496307
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of nor-androstenolone phenylpropionate (Durabolin) on weight increase in atrophic children].
    UJSAGHY P
    Gyermekgyogyaszat; 1962 Jul; 13():210-8. PubMed ID: 13923627
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the anabolic action of 19-nortestosterone phenylpropionate. Preliminary note].
    de SALCEDO ; BORGES F; GODINHO P
    J Med (Oporto); 1960 Nov; 43():599-600. PubMed ID: 13831238
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of nor-androstenolone phenylpropionate in premature infants of the Congo].
    HUGON J
    Brux Med; 1959 May; 39(18):627-33. PubMed ID: 13651796
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of 19-nor-androstenolone phenylpropionate (durabolin) to prevent the alterations produced by cortisone on the growing bone in rats.
    LARON Z; BOSS JH
    Endocrinology; 1961 Sep; 69():608-12. PubMed ID: 13759150
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of the treatment of dystrophia musculorum progressiva with an anabolic steroid: nor-androstenolone decanoate.
    PATEISKY K; SCHINKO H; HABERLER H
    Acta Endocrinol Suppl (Copenh); 1961; 39(Suppl 63)():185-98. PubMed ID: 14484294
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of the antithyrotoxic effects of a protein-anabolic testosterone derivative (1-methyl-delta1-androstenolone)].
    KRUESKEMPER HL; KESSLER FJ; HASSAN SH
    Klin Wochenschr; 1961 Oct; 39():1013-8. PubMed ID: 14459898
    [No Abstract]   [Full Text] [Related]  

  • 14. [ACTION OF 19-NOR-ANDROSTENOLONE PHENYLPROPIONATE ON THE RECOVERY OF PANIRRADIATED ANIMALS].
    CAPRINO G; GALLINA F
    Boll Soc Ital Biol Sper; 1963 Dec; 39():1687-91. PubMed ID: 14124843
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anabolism and metabolic effects during treatment with nor-androstenolone phenyl-propionate].
    DEMOL R; THIERY M; FRANCOIS-TERMONT E; BEKAERT J; PEETERS H; VUYLSTEKE P
    Brux Med; 1960 Mar; 40():391-413. PubMed ID: 13815849
    [No Abstract]   [Full Text] [Related]  

  • 16. Some uses of nor-adrostenolone phenylpropionate in pediatric practice.
    BELMONTE CR; LOPEZ RN; GUERRERO RM
    J Philipp Med Assoc; 1959 Jun; 35():354-65. PubMed ID: 13798629
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical use of norandrostenolone phenylpropionate].
    VAN OS H; DEMEULEMEESTER J
    Bull Soc Sci Med Grand Duche Luxemb; 1959 Oct; 96():287-307. PubMed ID: 13841117
    [No Abstract]   [Full Text] [Related]  

  • 18. Some metabolic effects of a new parenteral anabolic agent.
    DARGAN EL; METCALF W
    Surg Forum; 1960; 10():331-4. PubMed ID: 13814093
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of norandrostenolone phenylpropionate on the riboflavin content of blood.
    MARKKANEN T
    Ann Med Intern Fenn; 1962; 51():125-7. PubMed ID: 14469994
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical effect of norandrostenolone phenylpropionate (durabolin) in metastasizing mammary cancer patients.
    MALMIO K; HISI-BRUMMER L; HORTLING H
    Ann Med Intern Fenn; 1960; 49():121-29. PubMed ID: 14420398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.